Rain Oncology Inc reports results for the quarter ended in March - Earnings Summary

Rain Oncology

11/05/2023 22:07

* Rain Oncology Inc  RAIN.OQ  reported a quarterly adjusted
loss
of 56 cents​​ per share for the quarter ended in March. The mean
expectation of eleven analysts for the quarter was for a loss
of 62 cents per share.
    * Reported revenue was zero​; analysts expected zero. 
    * Rain Oncology Inc's reported EPS for the quarter was a
loss
of 56 cents​.
    * The mean earnings estimate of analysts had fallen by
about 22.8%
in the last three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * Rain Oncology Inc shares had risen by 4.7% this
quarter and
gained 14.4% so far this year.
    * The company reported a quarterly loss of $20.48 million.
    * Wall Street's median 12-month price target for Rain
Oncology Inc
is $18.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 11 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data May
11 at 09:07 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Mar. 31 2023      -0.62          -0.56          Beat
 Dec. 31 2022      -0.56          -0.70          Missed
 Sep. 30 2022      -0.69          -0.68          Beat
 Jun. 30 2022      -0.66          -0.66          Met